ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant.
作者信息
Falchi L, Mehrotra M, Newberry K J, Lyle L M, Lu G, Patel K P, Luthra R, Popat U, Verstovsek S
机构信息
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Leukemia. 2014 Oct;28(10):2090-2. doi: 10.1038/leu.2014.168. Epub 2014 May 23.
Abstract
摘要
相似文献
1
ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant.
Leukemia. 2014 Oct;28(10):2090-2. doi: 10.1038/leu.2014.168. Epub 2014 May 23.
2
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
Blood. 2011 Aug 25;118(8):2239-42. doi: 10.1182/blood-2011-03-343426. Epub 2011 Jun 24.
3
Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia.
Ann Hematol. 2014 Mar;93(3):535-7. doi: 10.1007/s00277-013-1843-9. Epub 2013 Jul 20.
4
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation.
Eur J Cancer. 2017 Nov;86:233-239. doi: 10.1016/j.ejca.2017.09.016. Epub 2017 Oct 18.
5
Use of sorafenib for post-transplant relapse in FLT3/ITD-positive acute myelogenous leukemia: maturation induction and cytotoxic effect.
Haematologica. 2014 Nov;99(11):e222-4. doi: 10.3324/haematol.2014.109975. Epub 2014 Jul 11.
6
FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation.
Leukemia. 2006 Aug;20(8):1414-21. doi: 10.1038/sj.leu.2404266. Epub 2006 Jun 8.
7
Two myeloid leukemia cases with rare fusions.
Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6). doi: 10.1101/mcs.a003079. Print 2018 Dec.
8
Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
J Cancer Res Clin Oncol. 2017 Feb;143(2):337-345. doi: 10.1007/s00432-016-2290-5. Epub 2016 Oct 24.
9
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation.
Ann Hematol. 2015 Nov;94(11):1899-905. doi: 10.1007/s00277-015-2461-5. Epub 2015 Aug 2.
10
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Leuk Res. 2020 Dec;99:106460. doi: 10.1016/j.leukres.2020.106460. Epub 2020 Oct 6.
引用本文的文献
1
Fusion Genes in Myeloid Malignancies.
Cancers (Basel). 2024 Dec 3;16(23):4055. doi: 10.3390/cancers16234055.
2
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).
Cells. 2024 Jul 11;13(14):1180. doi: 10.3390/cells13141180.
3
Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals.
Curr Hematol Malig Rep. 2024 Oct;19(5):208-222. doi: 10.1007/s11899-024-00738-7. Epub 2024 Jul 22.
4
Hematological Neoplasms with Eosinophilia.
Cancers (Basel). 2024 Jan 12;16(2):337. doi: 10.3390/cancers16020337.
5
T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Virchows Arch. 2024 May;484(5):853-857. doi: 10.1007/s00428-023-03693-5. Epub 2023 Nov 20.
6
Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.
Acta Haematol. 2023;146(5):401-407. doi: 10.1159/000529844. Epub 2023 Feb 27.
7
A gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature.
Cold Spring Harb Mol Case Stud. 2023 Mar 24;9(1). doi: 10.1101/mcs.a006243. Print 2023 Feb.
8
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation.
Clin Hematol Int. 2020 Jul 27;2(3):129-131. doi: 10.2991/chi.k.200714.001. eCollection 2020 Sep.
9
ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML.
Blood Adv. 2021 Apr 13;5(7):1899-1902. doi: 10.1182/bloodadvances.2020003699.
10
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
Int J Mol Sci. 2021 Jan 6;22(2):486. doi: 10.3390/ijms22020486.
本文引用的文献
1
B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.
Mod Pathol. 2014 Mar;27(3):382-9. doi: 10.1038/modpathol.2013.149. Epub 2013 Sep 13.
2
Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia.
Ann Hematol. 2014 Mar;93(3):535-7. doi: 10.1007/s00277-013-1843-9. Epub 2013 Jul 20.
3
Direct binding of Grb2 has an important role in the development of myeloproliferative disease induced by ETV6/FLT3.
Leukemia. 2013 Jun;27(6):1433-6. doi: 10.1038/leu.2012.333. Epub 2012 Nov 20.
4
ETV6 fusion genes in hematological malignancies: a review.
Leuk Res. 2012 Aug;36(8):945-61. doi: 10.1016/j.leukres.2012.04.010. Epub 2012 May 12.
5
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
Blood. 2011 Aug 25;118(8):2239-42. doi: 10.1182/blood-2011-03-343426. Epub 2011 Jun 24.
6
The juxtamembrane domain in ETV6/FLT3 is critical for PIM-1 up-regulation and cell proliferation.
Biochem Biophys Res Commun. 2009 Jun 5;383(3):308-13. doi: 10.1016/j.bbrc.2009.03.157. Epub 2009 Apr 5.
7
FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation.
Leukemia. 2006 Aug;20(8):1414-21. doi: 10.1038/sj.leu.2404266. Epub 2006 Jun 8.
8
The role of FLT3 in haematopoietic malignancies.
Nat Rev Cancer. 2003 Sep;3(9):650-65. doi: 10.1038/nrc1169.
9
Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene.
Genomics. 1991 Feb;9(2):380-5. doi: 10.1016/0888-7543(91)90270-o.
10
A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations.
Cell. 1991 Jun 28;65(7):1143-52. doi: 10.1016/0092-8674(91)90010-v.
Zotero 插件